Leadership Update: Adastra Appoints Lachlan McLeod as CFO

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Leadership Update: Adastra Appoints Lachlan McLeod as CFO2023-02-14T12:32:34+00:00

Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House2023-02-09T12:37:44+00:00

Adastra Holdings Reports Third Quarter Results; Demonstrating Third Consecutive Quarter of Record Revenue

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Reports Third Quarter Results; Demonstrating Third Consecutive Quarter of Record Revenue2023-01-27T21:33:56+00:00

Adastra Receives Controlled Substances Dealer’s License

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Receives Controlled Substances Dealer’s License2023-01-27T23:07:09+00:00

Adastra Signs Option to Terminate Legacy Supply Agreement to Streamline Operations and Maximize Revenue 

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Signs Option to Terminate Legacy Supply Agreement to Streamline Operations and Maximize Revenue 2023-01-27T21:37:20+00:00

Adastra Holdings Reports Record Second Quarter Results; Momentum Accelerating in Second Half of the Year

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Reports Record Second Quarter Results; Momentum Accelerating in Second Half of the Year2023-01-27T21:38:38+00:00

Adastra Announces Grant of Stock Options

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Announces Grant of Stock Options2023-01-27T21:39:57+00:00

Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canada

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canada2023-01-27T21:41:48+00:00

Adastra Holdings Continues to Execute on Transformational Strategy; New Product Launches; Outlines Growth Strategy

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Continues to Execute on Transformational Strategy; New Product Launches; Outlines Growth Strategy2023-01-27T21:45:43+00:00

Adastra Holdings Reports First Quarter Results

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Reports First Quarter Results2023-01-27T23:11:15+00:00
Go to Top